Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease.

Amuah, Joseph E; Hogan, David B; Eliasziw, Misha; Supina, Alison; Beck, Patricia; Downey, Winanne; Maxwell, Colleen J

Amuah, Joseph E; Hogan, David B; Eliasziw, Misha; Supina, Alison; Beck, Patricia; Downey, Winanne; Maxwell, Colleen J.

Affiliation

Amuah JE; Methodology Unit, Canadian Institute for Health Information, Ottawa, Ontario, Canada.

Pharmacoepidemiol Drug Saf ; 19(7): 670-9, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20583207

Subject(s)

Alzheimer Disease/drug therapy; Cholinesterase Inhibitors/therapeutic use; Aged; Aged, 80 and over; Cholinesterase Inhibitors/administration & dosage; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Male; Neuropsychological Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Saskatchewan; Sex Factors; Socioeconomic Factors; Time Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholinesterase Inhibitors / Alzheimer Disease Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google